These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8865253)

  • 1. Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia.
    Stone RC; Vale P; Rosa FC
    Pediatr Nephrol; 1996 Aug; 10(4):501-3. PubMed ID: 8865253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
    Mayan H; Vered I; Mouallem M; Tzadok-Witkon M; Pauzner R; Farfel Z
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3248-54. PubMed ID: 12107233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypoaldosteronism with pyloric stenosis--a patient report.
    Wang YM
    J Pediatr Endocrinol Metab; 1997; 10(4):429-31. PubMed ID: 9364371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrocalcinosis in pseudohypoaldosteronism and the effect of indomethacin therapy.
    Shalev H; Ohali M; Abramson O
    J Pediatr; 1994 Aug; 125(2):246-8. PubMed ID: 8040773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium transport and bone mineral density in hypercalciuria with thiazide treatment.
    Reusz GS; Dobos M; Vásárhelyi B; Sallay P; Szabó A; Horváth C; Szabó A; Byrd DJ; Thole HH; Tulassay T
    Pediatr Nephrol; 1998 Jan; 12(1):30-4. PubMed ID: 9502564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II.
    Erdoğan G; Corapçioğlu D; Erdoğan MF; Hallioğlu J; Uysal AR
    J Endocrinol Invest; 1997 Dec; 20(11):681-4. PubMed ID: 9492109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dwarfism, arterial hypertension and hyperkalemic acidosis corrected with thiazides. A case of type II pseudohypoaldosteronism].
    Poujol A; Rimet Y; Cournelle MA; Cornus P; Frayssinet R; Zarrouk F; Brusquet Y
    Arch Fr Pediatr; 1993 Feb; 50(2):127-30. PubMed ID: 8343018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe systemic type 1 pseudohypoaldosteronism: 5 years of evolution.
    Gomes MM; Martins S; Marques O; Silva ND; Antunes A
    Endocrinol Nutr; 2016 Nov; 63(9):502-505. PubMed ID: 27651040
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.
    Sato K; Hasegawa Y; Nakae J; Nanao K; Takahashi I; Tajima T; Shinohara N; Fujieda K
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3068-73. PubMed ID: 12107202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential hypertension: new insights and controversies in treatment with diuretics.
    Houston MC; Johnston PE
    South Med J; 1986 Aug; 79(8):984-90. PubMed ID: 3526575
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ; McNamee R; Carr M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohypoaldosteronism with normal blood pressure.
    Shoker A; Morris G; Skomro R; Laxdal V
    Clin Nephrol; 1996 Aug; 46(2):105-11. PubMed ID: 8869787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperkalemia, acidosis, and short stature associated with a defect in renal potassium excretion.
    Weinstein SF; Allan DM; Mendoza SA
    J Pediatr; 1974 Sep; 85(3):355-8. PubMed ID: 4431495
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide.
    Adams JS; Song CF; Kantorovich V
    Ann Intern Med; 1999 Apr; 130(8):658-60. PubMed ID: 10215562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion.
    Frassetto LA; Nash E; Morris RC; Sebastian A
    Kidney Int; 2000 Aug; 58(2):748-52. PubMed ID: 10916098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.
    Knauf H; Mutschler E
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):394-400. PubMed ID: 8583780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An infant presenting with failure to thrive and hyperkalaemia owing to transient pseudohypoaldosteronism: case report.
    De Clerck M; Vande Walle J; Dhont E; Dehoorne J; Keenswijk W
    Paediatr Int Child Health; 2018 Nov; 38(4):277-280. PubMed ID: 28557682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrochlorothiazide in CLDN16 mutation.
    Zimmermann B; Plank C; Konrad M; Stöhr W; Gravou-Apostolatou C; Rascher W; Dötsch J
    Nephrol Dial Transplant; 2006 Aug; 21(8):2127-32. PubMed ID: 16595585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.
    Mayan H; Munter G; Shaharabany M; Mouallem M; Pauzner R; Holtzman EJ; Farfel Z
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4025-30. PubMed ID: 15292344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?].
    Ader JL; Waeber B; Suc JM; Brunner HR; Tran-Van T; Durand D; Praddaude F
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():193-7. PubMed ID: 2973296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.